Blog Category

Press Releases

Biophytis announces US centers to restart recruitment for the COVA phase 2-3 study with Sarconeos (BIO101) in COVID-19

,

/

15 November 2021

Biophytis to Report Restated Financial Statements for Previous Periods and as of June 30, 2021

/

29 October 2021

OCTOBRE 07, 2021

/

7 October 2021

Biophytis to host virtual KOL event on Sarconeos (BIO101) on its lead projects in COVID-19 and Sarcopenia

/

6 October 2021

Biophytis announces the drawing of 2 new tranches of ORNANE under the 2020 Atlas Contract for €6 million

/

4 October 2021

Biophytis announces promising full results from the SARA-INT Phase 2b trial of Sarconeos (BIO101) in Sarcopenia at the 11th annual International Conference on Frailty and Sarcopenia Research (ICFSR) September 29 – October 2, 2021

/

4 October 2021

Biophytis publishes its interim financial report for the first half of 2021 and provides updates on key operational developments and financing transactions

, , ,

/

17 September 2021

Biophytis announces DMC second interim analysis efficacy results in the promising zone allowing continuation of phase 2/3 COVA study with Sarconeos (BIO101) in COVID-19

,

/

15 September 2021

Biophytis to attend key upcoming investor events and industry conferences

,

/

14 September 2021

ICFSR 2021 – International Conference on Frailty & Sarcopenia Research

,

/

10 September 2021

Biophytis leadership is reinforced with new Chief Medical Officer appointment

,

/

9 September 2021

Biophytis receives favorable recommendation from Data Monitoring Committee (DMC) based on safety analysis of Sarconeos (BIO101) to continue patients recruitment in the COVA study in COVID-19

/

16 August 2021